Clinical impact of complement (C1q, C3d) binding De Novo donor-specific HLA antibody in kidney transplant recipients.

Hyeyoung LeeEunhee HanAe-Ran ChoiTae Hyun BanByung Ha ChungChul Woo YangYeong Jin ChoiEun Jee Oh

Published in: PloS one (2018)

Detection of complement binding activity using both C1q and C3d assays can be a further prognostic marker for predicting AMR and allograft outcome in dnDSA+ kidney transplant patients.

Keyphrases

end stage renal disease
ejection fraction
chronic kidney disease
newly diagnosed
prognostic factors
binding protein
transcription factor
kidney transplantation